Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

NCT05873361 | Active Not Recruiting

• 2 other identifiers: RC31/23/00592023-A00294-41
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients. The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Conditions

Papillary Carcinoma

Keywords

Papillary Carcinoma; Postoperative; Follow-up

Outcome Measures

Primary Outcomes (1)

• Overall survival

  Review of medical record

  10 years

Secondary Outcomes (6)

• Disease control rate

  10 years

• Surgical complications rate

  10 years

• Detection of recurrence rate

  10 years

• Recovery surgical or iratherapie recovery rate

  10 years

• Anxiety evaluation

  1 month

Study Arms (1)

Adult patients with a papillary microcarcinoma asymptomatic

Adult patients who have had a papillary microcarcinoma asymptomatic and who are followed.

Other: Questionnaire

Interventions

Questionnaire OTHER

The questionnaire is about hypocalcemia, dysphonia and anxiety. It will be carried out by phone call for 10 minutes

Adult patients with a papillary microcarcinoma asymptomatic

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with papillary microcarcinoma asymptomatic

You may qualify if:

• Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci \<10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017.
• Non opposition patient
• Affiliation to a social security scheme

You may not qualify if:

• Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement.
• Patient under guardianship, curators or safeguard of justice

Sponsors & Collaborators

• University Hospital, Toulouse: lead

Study Sites (1)

UHToulouse

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Carcinoma, Papillary

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Squamous Cell

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Agnès DUPRET-BORIES, MD

  University Hospital, Toulouse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 15, 2023
• First Posted: May 24, 2023
• Study Start: May 15, 2023
• Primary Completion (Estimated): May 15, 2027
• Study Completion (Estimated): May 15, 2027
• Last Updated: June 22, 2023

Record last verified: 2023-06

Locations

FR (1)